The reliability and validity of PHQ-9 in patients with major depressive disorder in psychiatric hospital

被引:180
|
作者
Sun, Yue [1 ,2 ,3 ,4 ]
Fu, Zhaoyan [1 ,2 ,3 ,4 ]
Bo, Qijing [1 ,2 ,3 ,4 ]
Mao, Zhen [1 ,2 ,3 ,4 ]
Ma, Xin [1 ,2 ,3 ,4 ]
Wang, Chuanyue [1 ,2 ,3 ,4 ]
机构
[1] Capital Med Univ, Natl Clin Res Ctr Mental Disorders, Beijing Anding Hosp, 5 Ankang Lane,Dewai Ave, Beijing 100088, Peoples R China
[2] Capital Med Univ, Beijing Key Lab Mental Disorders, Beijing Anding Hosp, 5 Ankang Lane,Dewai Ave, Beijing 100088, Peoples R China
[3] Capital Med Univ, Beijing Inst Brain Disorders Ctr Schizophrenia, Beijing Anding Hosp, 5 Ankang Lane,Dewai Ave, Beijing 100088, Peoples R China
[4] Capital Med Univ, Adv Innovat Ctr Human Brain Protect, Beijing 100069, Peoples R China
基金
中国国家自然科学基金;
关键词
PHQ-9; Reliability; Validity; Major depressive disorder; HEALTH QUESTIONNAIRE PHQ-9; DIAGNOSTIC-ACCURACY; VALIDATION; VERSION; SYMPTOMS; POPULATION;
D O I
10.1186/s12888-020-02885-6
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background To assess the reliability and validity of Patient Health Questionnaire-9 (PHQ-9) for patients with major depressive disorder (MDD) and to assess the feasibility of its use in psychiatric hospitals in China. Methods One hundred nine outpatients or inpatients with MDD who qualified the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) criteria completed PHQ-9 and Hamilton Depression Scale (HAMD-17). Two weeks after the initial evaluation, 54 randomly selected patients underwent repeat assessment using PHQ-9. For validity analysis, the construct validity and criterion validity were assessed. The internal concordance coefficient and the test-retest correlation coefficients were used for reliability analysis. The correlation between total score and scores for each item and the correlation between scores for various items were evaluated using Pearson correlation coefficient. Results Principal components factor analysis showed good construct validity of the PHQ-9. PHQ-9 total score showed a positive correlation with HAMD-17 total score (r=0.610, P<0.001). With HAMD as the standard, PHQ-9 depression scores of 7, 15, and 21 points were used as cut-offs for mild, moderate, and severe depression, respectively. Consistency assessment was conducted between the depression severity as assessed by PHQ-9 and HAMD (Kappa=0.229, P<0.001). Intraclass correlation coefficient between PHQ-9 total score and HAMD total score was 0.594 (95% confidence interval, 0.456-0.704, P<0.001). The Cronbach's alpha coefficient of PHQ-9 was 0.892. Correlation coefficients between each item score and the total score ranged from 0.567-0.789 (P<0.01); the correlation coefficient between various item scores ranged from 0.233-0.747. The test-retest correlation coefficient for total score was 0.737. Conclusions PHQ-9 showed good reliability and validity, and high adaptability for patients with MDD in psychiatric hospital. It is a simple, rapid, effective, and reliable tool for screening and evaluation of the severity of depression.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Reliability and validity of PHQ-9 when administered by health workers for depression screening among women in primary care
    Indu, Pillaveetil Sathyadas
    Anilkumar, Thekkethayyil Viswanathan
    Vijayakumar, Krishnapillai
    Kumar, K. A.
    Sarma, P. Sankara
    Remadevi, Saradamma
    Andrade, Chittaranjan
    ASIAN JOURNAL OF PSYCHIATRY, 2018, 37 : 10 - 14
  • [32] Assessment of depression severity with the PHQ-9 in cancer patients and in the general population
    Hinz, Andreas
    Mehnert, Anja
    Kocalevent, Rueya-Daniela
    Braehler, Elmar
    Forkmann, Thomas
    Singer, Susanne
    Schulte, Thomas
    BMC PSYCHIATRY, 2016, 16
  • [33] Utility of PHQ-2, PHQ-8 and PHQ-9 for detecting major depression in primary health care: a validation study in Spain
    Gomez-Gomez, Irene
    Benitez, Isabel
    Bellon, Juan
    Moreno-Peral, Patricia
    Olivan-Blazquez, Barbara
    Claveria, Ana
    Zabaleta-del-Olmo, Edurne
    Llobera, Joan
    Serrano-Ripoll, Maria J.
    Tamayo-Morales, Olaya
    Motrico, Emma
    PSYCHOLOGICAL MEDICINE, 2023, 53 (12) : 5625 - 5635
  • [34] Identify depressive phenotypes by applying RDOC domains to the PHQ-9
    Gunzler, Douglas
    Sehgal, Ashwini R.
    Kauffman, Kelley
    Davey, Christine Horvat
    Dolata, Jacqueline
    Figueroa, Maria
    Huml, Anne
    Pencak, Julie
    Sajatovic, Martha
    PSYCHIATRY RESEARCH, 2020, 286
  • [35] Utility and limitations of PHQ-9 in a clinic specializing in psychiatric care
    Takeshi Inoue
    Teruaki Tanaka
    Shin Nakagawa
    Yasuya Nakato
    Rie Kameyama
    Shuken Boku
    Hiroyuki Toda
    Tsugiko Kurita
    Tsukasa Koyama
    BMC Psychiatry, 12
  • [36] Translating measurement into practice: Brazilian norms for depressive symptom assessment with the Patient Health Questionnaire (PHQ-9)
    Damiano, Rodolfo Furlan
    Hoffmann, Mauricio Scopel
    Gosmann, Natan Pereira
    Pan, Pedro Mario
    Miguel, Euripedes Constantino
    Salum, Giovanni Abrahao
    BRAZILIAN JOURNAL OF PSYCHIATRY, 2023, 45 (04) : 310 - 317
  • [37] Psychometric evaluation and linking of the PHQ-9, QIDS-C, and VQIDS-C in a real-world population with major depressive disorder
    Palmer, Emily O. C.
    Ker, Sheryl
    Renteria, Miguel E.
    Carmody, Thomas
    Rush, A. John
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2024, 20 : 671 - 687
  • [38] Validity of the PHQ-9 and PHQ-2 to screen for depression in nationwide primary care population in Latvia
    Elmars Rancans
    Marcis Trapencieris
    Rolands Ivanovs
    Jelena Vrublevska
    Annals of General Psychiatry, 17
  • [39] Validity of the PHQ-9 and PHQ-2 to screen for depression in nationwide primary care population in Latvia
    Rancans, Elmars
    Trapencieris, Marcis
    Ivanovs, Rolands
    Vrublevska, Jelena
    ANNALS OF GENERAL PSYCHIATRY, 2018, 17
  • [40] Relationship between Patient Health Questionnaire (PHQ-9) and Montgomery-Asberg Depression Rating Scale (MADRS) total scores in older adults with major depressive disorder: An analysis of the OPTIMUM clinical trial
    Kim, Helena K.
    Lenze, Eric J.
    Ainsworth, Nicholas J.
    Blumberger, Daniel M.
    Brownd, Patrick J.
    Flint, Alastair J.
    Karpf, Jordan F.
    Lavretskyg, Helen
    Lenard, Emily
    Miller, J. Philip
    Reynolds, Charles F.
    Roosed, Steven P.
    Mulsanta, Benoit H.
    JOURNAL OF AFFECTIVE DISORDERS, 2024, 361 : 651 - 658